Search alternatives:
significantly weaker » significantly greater (Expand Search), significantly better (Expand Search), significantly related (Expand Search)
significantly lower » significantly higher (Expand Search)
significantly teer » significantly better (Expand Search), significantly alter (Expand Search), significantly older (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
Showing 341 - 360 results of 3,725 for search '(( significantly lower decrease ) OR ( ((significantly teer) OR (significantly weaker)) decrease ))', query time: 0.61s Refine Results
  1. 341
    Frequency of tobacco smoking among smokers.

    Frequency of tobacco smoking among smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 342
    Correlation of lung function parameters with smoking variables.

    Correlation of lung function parameters with smoking variables. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 343
    Anthropometric characteristics of smokers and non-smokers.

    Anthropometric characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 344
    Respiratory clinical characteristics of smokers and non-smokers.

    Respiratory clinical characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 345
    Effect of the smoking factor on lung function parameters (FVC, FEV1, PEF, FEF 25_75).

    Effect of the smoking factor on lung function parameters (FVC, FEV1, PEF, FEF 25_75). by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 346
    Lung function parameters between smokers and non-smokers.

    Lung function parameters between smokers and non-smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 347
    Supplementary file 1_Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.docx

    Supplementary file 1_Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.docx by Emmama Jamil (22005635)

    Published 2025
    Save to List
    Saved in:
  8. 348
    GLM models for predictors of monthly HIV costs.

    GLM models for predictors of monthly HIV costs. by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 349
    Median cost (USD) per visit breakdown.

    Median cost (USD) per visit breakdown. by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 350
    Descriptive statistics (means) for full sample and by lockdown status.

    Descriptive statistics (means) for full sample and by lockdown status. by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 351
    Study sites and number of participants enrolled in the KAP and OOP surveys.

    Study sites and number of participants enrolled in the KAP and OOP surveys. by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 352
    Average cost per visit for HIV and HTN care (absolute vs. relative contributions).

    Average cost per visit for HIV and HTN care (absolute vs. relative contributions). by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 353
    GLM models for predictors of monthly HTN care costs.

    GLM models for predictors of monthly HTN care costs. by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 354
    Median monthly care costs, projected visits, and hospitalization costs.

    Median monthly care costs, projected visits, and hospitalization costs. by Drew B. Cameron (10687420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 355
    Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n 

    Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 356
    Weekly resistance training frequency over time for the DHA and placebo groups combined (n 

    Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 357
    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.

    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 358
    Participant demographic and clinical characteristics.

    Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 359
    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic exercise recommendation on average during chemotherapy.

    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 360
    Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), randomized controlled trial (RCT).

    Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: